Inside Antitrust 2023: Navigating an evolving landscape

March 28, 2023

Cyto-PHL | Cira Center, 2929 Arch Street, Mezzanine Level, Philadelphia , PA, USA 19104

Dechert's antitrust/competition practice’s annual spring event Inside Antitrust 2023: Navigating an evolving landscape, covered the latest developments in the competition world. Featuring perspectives from the U.S., EU and UK, the event provided successful strategies for managing high-stakes antitrust litigation, transatlantic insight on how antitrust is reshaping industries and other areas of law, and the latest developments in mergers and acquisitions.

General session I: Litigating to win: Lessons from antitrust trials
Breakout session A: Antitrust and innovation collide: Insights for life sciences industries
Breakout session B: Tech in the crosshairs (and what it means for everyone else)
Breakout session C: Antitrust’s new focus on labor: What employers need to know
General session II: Closing the deal: Merger clearance for strategic acquisitions
Q&A: Brian Savage, Vice President & General Counsel, U.S. Antitrust & Commercial Litigation, Teva Pharmaceuticals

General Session I | Litigating to win: Lessons from antitrust trials

Hear strategies from U.S. and EU antitrust litigators on successfully navigating litigation, including through high-stakes trials. The panel also explores what sets apart antitrust trials and recent trends in antitrust litigation.

Dechert Speakers:

Julia Chapman, Partner, Philadelphia (moderator)
Steven Bizar, Partner, Philadelphia
George Gordon, Partner, Philadelphia
Jay Jurata, Partner, Washington, D.C.
Shari Ross Lahlou, Partner, Washington, D.C.
Mélanie Thill-Tayara, Partner, Paris

Review the CLE Materials

Breakout Session A | Antitrust and innovation collide: Insights for life sciences industries

Gain insights from lawyers across Dechert practices on how antitrust is reshaping the life sciences industry and other areas of law, particularly intellectual property.

Dechert Speakers:

John McClam, Partner, Philadelphia (moderator)
Amanda Antons, Partner, Chicago
George Gordon, Partner, Philadelphia
Marion Provost, Partner, Paris

Review the CLE Materials

Breakout Session B | Tech in the crosshairs (and what it means for everyone else)

In this timely panel covering all things high-tech, the antitrust practice reviews data's role, regulation's impact on large tech companies and the effects of legislation like the Digital Markets Act.

Dechert Speakers:

Marjolein De Backer, Partner, Paris (moderator)
Laurence Bary, Partner, Paris
Alec Burnside, Partner, Brussels
Russell Cohen, Partner, London
Saira Henry, Partner, London

Review the CLE Materials

Breakout Session C | Antitrust's new focus on labor: What employers need to know

Focusing on the intersection of antitrust and labor law, lawyers across Dechert practices provide insight on how antitrust is changing the way companies think about labor and employment law..

Dechert Speakers:

Thomas Miller, Associate, Philadelphia (moderator)
Steven Bizar, Partner, Philadelphia
J. Ian Downes, Partner, Philadelphia
Shari Ross Lahlou, Partner, Washington, D.C.

Review the CLE Materials

General Session II | Closing the deal: Merger clearance for strategic acquisitions

Review the latest updates on the shifting merger clearance landscape, and what in-house counsel need to understand from contemplating to closing strategic acquisitions.

Dechert Speakers:

Rani Habash, Partner, Washington, D.C. (moderator)
Mike Cowie, Partner, Washington, D.C.
James Fishkin, Partner, Washington, D.C.
Douglas Lahnborg, Partner, London
Allie Wasserman, Partner, Philadelphia

Review the CLE Materials

Q&A | Brian Savage, Vice President & General Counsel, U.S. Antitrust & Commercial Litigation, Teva Pharmaceuticals

In this feature Q&A, partner Julia Chapman and Teva Pharmaceuticals’ Brian Savage discuss how recent antitrust developments impact the pharmaceutical industry.

Speakers:

Julia Chapman, Partner, Philadelphia (moderator)
Brian Savage, Teva Pharmaceuticals, Vice President & General Counsel, U.S. Antitrust & Commercial Litigation